FY2026 Earnings Forecast for QIPT Issued By Leede Financial

Quipt Home Medical Corp. (NASDAQ:QIPT) – Equities research analysts at Leede Financial reduced their FY2026 earnings per share estimates for Quipt Home Medical in a report issued on Tuesday, February 11th. Leede Financial analyst D. Loe now expects that the company will post earnings per share of ($0.13) for the year, down from their previous estimate of ($0.12). The consensus estimate for Quipt Home Medical’s current full-year earnings is ($0.05) per share.

Quipt Home Medical Stock Performance

QIPT stock opened at $2.97 on Friday. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.20 and a quick ratio of 0.86. The business has a 50-day moving average price of $2.90 and a 200 day moving average price of $2.84. The company has a market capitalization of $127.98 million, a P/E ratio of -19.80 and a beta of 0.57. Quipt Home Medical has a 1-year low of $2.30 and a 1-year high of $4.98.

Quipt Home Medical (NASDAQ:QIPT) last released its quarterly earnings data on Monday, February 10th. The company reported ($0.03) earnings per share for the quarter. Quipt Home Medical had a negative net margin of 2.66% and a negative return on equity of 6.18%.

Hedge Funds Weigh In On Quipt Home Medical

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Northern Trust Corp grew its stake in Quipt Home Medical by 2.8% in the fourth quarter. Northern Trust Corp now owns 257,402 shares of the company’s stock valued at $785,000 after purchasing an additional 7,095 shares during the last quarter. TD Waterhouse Canada Inc. grew its stake in Quipt Home Medical by 83.4% in the fourth quarter. TD Waterhouse Canada Inc. now owns 27,435 shares of the company’s stock valued at $76,000 after purchasing an additional 12,479 shares during the last quarter. XTX Topco Ltd grew its stake in Quipt Home Medical by 54.3% in the fourth quarter. XTX Topco Ltd now owns 28,452 shares of the company’s stock valued at $87,000 after purchasing an additional 10,015 shares during the last quarter. Barclays PLC grew its stake in Quipt Home Medical by 9.7% in the fourth quarter. Barclays PLC now owns 95,916 shares of the company’s stock valued at $293,000 after purchasing an additional 8,491 shares during the last quarter. Finally, Raymond James Financial Inc. purchased a new position in Quipt Home Medical in the fourth quarter valued at about $113,000. Hedge funds and other institutional investors own 42.85% of the company’s stock.

Insider Activity at Quipt Home Medical

In related news, VP Patrick Dennis Gamble bought 17,000 shares of the business’s stock in a transaction on Thursday, December 26th. The shares were bought at an average price of $2.45 per share, for a total transaction of $41,650.00. Following the completion of the purchase, the vice president now directly owns 40,057 shares of the company’s stock, valued at approximately $98,139.65. This trade represents a 73.73 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 13.40% of the stock is currently owned by corporate insiders.

Quipt Home Medical Company Profile

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.